Health News

A drug used to treat asthma has been shown to help reduce the formation of amyloid beta, a peptide in the brain that is implicated in the development of Alzheimer’s disease, according to researchers at Temple University’s School of Medicine.

Read more

Filed under: Pharmacy News
Tags: brain, Drug, medicine, Pharmacy

Related posts

• Study looks at effects of antipsychotic drugs on two brain receptors linked to schizophrenia (0)
  Researchers from Mount Sinai School of Medicine, have identified the pattern of cell signaling induced by antipsychotic drugs in a complex composed of two brain receptors linked to schizophrenia. Read more [tags] Pharmacy News [/tags]
  
  
• Study In NEJM Shows Novartis Drug Afinitor® Reduces Size Of SEGAs, Benign Brain Tumors Associated With Tuberous Sclerosis (0)
  The New England Journal of Medicine (NEJM) published a study that found patients taking Afinitor® (everolimus) tablets experienced a decrease in the size of their subependymal giant cell astrocytoma (SEGA), a benign brain tumor associated with tuberous sclerosis (TS)(1,2)... Read more [tags] Pharmacy News [/tags]
  
  
• Mouse model could help develop new classes of antidepressant drugs (0)
  The most widely prescribed antidepressants - medicines such as Prozac, Lexapro and Paxil - work by blocking the serotonin transporter, a brain protein that normally clears away the mood-regulating chemical serotonin. Or so the current thinking goes. Read more [tags] Pharmacy News [/tags]
  
  
• Improved communication about medications reduces complications among patients using common blood thinner (0)
  Patients who report receiving written and verbal instructions on the proper way to take the blood thinner warfarin are significantly less likely to suffer the serious gastrointestinal and brain bleeding problems that are associated with misuse of the drug, according to new research from the University of Pennsylvania School of Medicine. Read more [tags]Pharmacy News[/tags]
  
  
• Diabetes drug pioglitazone shows potential against multiple sclerosis (0)
  A drug currently FDA-approved for use in diabetes shows some protective effects in the brains of patients with relapsing remitting multiple sclerosis, researchers at the University of Illinois at Chicago College of Medicine report in a study currently available online in the Journal of Neuroimmunology. Read more [tags] Pharmacy News [/tags]